Experiment summary for ENCSR000DSC
doi:10.17989/ENCSR000DSC
Summary
- Status
- released
- Assay
- ChIP-seq (Control ChIP-seq)
- Control type
- input library
- Biosample summary
- Homo sapiens mesodermal cell originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 2 days, 6 ng/mL Activin A for 2 days, 10 ng/mL Bone morphogenetic protein 4 for 2 days
- Biosample Type
- in vitro differentiated cells
- Replication type
- unreplicated
- Description
- Control ChIP-seq on human H7-hESC differentiated 2 days
- Treatments
- 5 ng/mL Fibroblast growth factor 2 (UniProtKB:P09038) for 2 days, 6 ng/mL Activin A (CHEBI:81351) for 2 days, 10 ng/mL Bone morphogenetic protein 4 (UniProtKB:P12644) for 2 days
- Nucleic acid type
- DNA
- Fragmentation methods
- see document
- Platform
- Illumina Genome Analyzer
Attribution
ENCODE2 project
- Lab
- John Stamatoyannopoulos, UW
- Award
- U54HG004592 (John Stamatoyannopoulos, UW)
- Project
- ENCODE
- External resources
- Date submitted
- June 25, 2011
- Date released
- February 16, 2012
- Reference Epigenome
- ENCSR675QUG
- Treatment Time Series
- ENCSR831IZS , ENCSR114LRH , ENCSR182ORV
- Submitter comment
- Replicate 1,1 of this experiment was previously attributed to biosample ENCBS295AAA but it has since been corrected to the current biosample. Please note that the biosample term has remain unchanged.
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Library |
|---|---|---|---|---|
| 1 | 1 | Homo sapiens female embryo mesodermal in vitro differentiated cells originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 2 days, 6 ng/mL Activin A for 2 days, 10 ng/mL Bone morphogenetic protein 4 for 2 days | ENCBS093MVN | ENCLB328HSH |